Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Hamel

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
BMC Genetics|May 18, 2010
How old is this mutation? - a study of three Ashkenazi Jewish founder mutationsCelia M T Greenwood, Shuying Sun, Justin Veenstra, et al.
BJC Reports|November 8, 2024
Founder pathogenic variants in colorectal neoplasia susceptibility genes in Ashkenazi Jews undergoing colonoscopyThibaut Matis, Celine Domecq, Nancy Hamel, et al.
Genes, Chromosomes & Cancer|April 9, 2026
Causative Role for a BRCA2 Germline Pathogenic Variant in External Auditory Canal Squamous Cell CarcinomaJosé Camacho-Valenzuela, Dylan Pelletier, Paz Polak, et al.
Scientific Reports|April 18, 2020
Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controlsSupriya Behl, Nancy Hamel, Manon de Ladurantaye, et al.
Nature Reviews. Urology|January 16, 2013
Familial prostate cancer: the damage done and lessons learntNassim Taherian, Nancy Hamel, Louis R Bégin, et al.
BMC Medical Genetics|March 3, 2006
The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populationsTeresa M Rudkin, Nancy Hamel, Maria Galvez, et al.
BMC Medical Genetics|January 11, 2013
Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descentMarc Tischkowitz, Nelly Sabbaghian, Nancy Hamel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2009
Relationship between angiotensin-converting enzyme gene polymorphism and body composition, functional performance, and blood biomarkers in advanced cancer patientsAntonio Vigano, Barbara Trutschnigg, Robert D Kilgour, et al.
Carcinogenesis|November 25, 2003
Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin geneAthena Matakidou, Nancy Hamel, Sanjay Popat, et al.
Cancer Research|March 17, 2019
SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain InhibitorsTatiana Shorstova, Maud Marques, Jie Su, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
BMC Genetics|May 18, 2010
How old is this mutation? - a study of three Ashkenazi Jewish founder mutationsCelia M T Greenwood, Shuying Sun, Justin Veenstra, et al.
BJC Reports|November 8, 2024
Founder pathogenic variants in colorectal neoplasia susceptibility genes in Ashkenazi Jews undergoing colonoscopyThibaut Matis, Celine Domecq, Nancy Hamel, et al.
Genes, Chromosomes & Cancer|April 9, 2026
Causative Role for a BRCA2 Germline Pathogenic Variant in External Auditory Canal Squamous Cell CarcinomaJosé Camacho-Valenzuela, Dylan Pelletier, Paz Polak, et al.
Scientific Reports|April 18, 2020
Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controlsSupriya Behl, Nancy Hamel, Manon de Ladurantaye, et al.
Nature Reviews. Urology|January 16, 2013
Familial prostate cancer: the damage done and lessons learntNassim Taherian, Nancy Hamel, Louis R Bégin, et al.
BMC Medical Genetics|March 3, 2006
The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populationsTeresa M Rudkin, Nancy Hamel, Maria Galvez, et al.
BMC Medical Genetics|January 11, 2013
Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descentMarc Tischkowitz, Nelly Sabbaghian, Nancy Hamel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2009
Relationship between angiotensin-converting enzyme gene polymorphism and body composition, functional performance, and blood biomarkers in advanced cancer patientsAntonio Vigano, Barbara Trutschnigg, Robert D Kilgour, et al.
Carcinogenesis|November 25, 2003
Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin geneAthena Matakidou, Nancy Hamel, Sanjay Popat, et al.
Cancer Research|March 17, 2019
SWI/SNF-Compromised Cancers Are Susceptible to Bromodomain InhibitorsTatiana Shorstova, Maud Marques, Jie Su, et al.
Pageof 7